A Review of Adapalene in the Treatment of Acne Vulgaris

Journal of Adolescent Health

Volumn 43, Issue 5, 2008, Pages 421-424

  Irby, Cynthia E ^a   Yentzer, Brad A ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Anti inflammatory; Comedolytic; Pediatricians; Topical retinoids; Tretinoin

Indexed keywords

ADAPALENE; BENZOYL PEROXIDE; CLINDAMYCIN; DOXYCYCLINE; ISOTRETINOIN; RETINOIC ACID; SALICYLIC ACID;

ACNE VULGARIS; CLINICAL EFFECTIVENESS; CLINICAL STUDY; CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG USE; DRY SKIN; ERYTHEMA; HUMAN; PAPULAR RASH; PAPULOVESICULAR RASH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRURITUS; REVIEW; SKIN BURNING SENSATION; SKIN EDEMA; TREATMENT INDICATION;

ACNE VULGARIS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMANS; NAPHTHALENES; RETINOIDS;

EID: 53249109434     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jadohealth.2008.06.005     Document Type: Review

References (21)

1. Webster G.F. The pathophysiology of acne. Cutis 76 2 Suppl (2005) 4-7
2. Shalita A. The integral role of topical and oral retinoids in the early treatment of acne. J Eur Acad Dermatol Venereol 15 Suppl 3 (2001) 43-49
3. Czernielewski J., Michel S., Bouclier M., et al. Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne. J Eur Acad Dermatol Venereol 15 Suppl 3 (2001) 5-12
4. Galderma Laboratories L.P. Differin (adapalene gel) Gel, 0.3% Product Insert. http://www.differin.com/AboutDifferin/ProductInsert_Gel03.aspx Accessed October 14, 2007
5. Akhavan A., and Bershad S. Topical acne drugs: Review of clinical properties, systemic exposure, and safety. Am J Clin Dermatol 4 (2003) 473-492
6. Martin B., Meunier C., Montels D., and Watts O. Chemical stability of adapalene and tretinoin when combined with benzoyl peroxide in presence and in absence of visible light and ultraviolet radiation. Br J Dermatol 139 Suppl 52 (1998) 8-11
7. Galvin S.A., Gilbert R., Baker M., et al. Comparative tolerance of adapalene 0.1% gel and six different tretinoin formulations. Br J Dermatol 139 Suppl 52 (1998) 34-40
8. Shroot B., and Michel S. Pharmacology and chemistry of adapalene. J Am Acad Dermatol 36 6 Pt 2 (1997) S96-S103
9. Bouclier M., Chatelus A., Ferracin J., et al. Quantification of epidermal histological changes induced by topical retinoids and CD271 in the rhino mouse model using a standardized image analysis technique. Skin Pharmacol 4 (1991) 65-73
10. Ellis C.N., Millikan L.E., Smith E.B., et al. Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgaris. Br J Dermatol 139 Suppl 52 (1998) 41-47
11. Grosshans E., Marks R., Mascaro J.M., et al. Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life. Br J Dermatol 139 Suppl 52 (1998) 26-33
12. Nyirady J., Grossman R.M., Nighland M., et al. A comparative trial of two retinoids commonly used in the treatment of acne vulgaris. J Dermatol Treat 12 (2001) 149-157
13. Thiboutot D., Pariser D.M., Egan N., et al. Adapalene gel 0.3% for the treatment of acne vulgaris: A multicenter, randomized, double-blind, controlled, phase III trial. J Am Acad Dermatol 54 (2006) 242-250
14. Thiboutot D.M., Shalita A.R., Yamauchi P.S., et al. Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: A randomized, controlled, investigator-blind follow-up of a recent combination study. Arch Dermatol 142 (2006) 597-602
15. Wolf Jr. J.E., Kaplan D., Kraus S.J., et al. Efficacy and tolerability of combined topical treatment of acne vulgaris with adapalene and clindamycin: A multicenter, randomized, investigator-blinded study. J Am Acad Dermatol 49 3 Suppl (2003) S211-S217
16. Thiboutot D.M., Shalita A.R., Yamauchi P.S., et al. Combination therapy with adapalene gel 0.1% and doxycycline for severe acne vulgaris: A multicenter, investigator-blind, randomized, controlled study. Skinmed 4 (2005) 138-146
17. Wolf Jr. J.E. Safety and tolerability in the MORE trial. Cutis 78 1 Suppl (2006) 19-25
18. Balkrishnan R., Fleischer Jr. A.B., Paruthi S., and Feldman S.R. Physicians underutilize topical retinoids in the management of acne vulgaris: Analysis of U.S. National Practice Data. J Dermatol Treat 14 (2003) 172-176
19. Yentzer B.A., Irby C.E., Fleischer A.B., and Feldman S.R. Differences in acne treatment prescribing patterns of pediatricians and dermatologists: An analysis of nationally representative data. Pediatr Dermatol (2008) In press
20. Gollnick H., Cunliffe W., Berson D., et al. Management of acne: A report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 49 1 Suppl Part 2 (2003) S1-S37
21. Drugstore.com. http://www.drugstore.com Accessed May 8, 2008